Hartford HealthCare professional discusses weight loss drug approved by FDA to combat obesity

Good Morning CT at Nine

(WTNH) — FDA approved a weight loss drug to fight the ongoing battle against obesity. According to the Centers for Disease Control and Prevention, 42.4% of all adults in the U.S. suffer from obesity.

Director of Metabolic and Bariatric Surgery at Hartford Healthcare St. Vincent’s Medical Center Dr. Craig Floch breaks down how Semaglutide may be a potential game changer.

Semaglutide is an injectable drug made by the pharmaceutical company Novo Nordisk. The drug targets patients with a BMI over 30, or a BMI over 27.

Semaglutide was approved in 2019 by the FDA to treat Type 2 diabetes. To learn more about surgical and non-surgical options for weight loss go to myweightisover.com.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.


CT leaders to raise awareness of Act that would close Purdue Pharma bankruptcy loophole

News /

Get your COVID vaccine at McDonalds in Enfield

News /

Over 700 CT People's United Bank employees to be laid off following bank merger

News /

Lake Compounce kicks off 'Christmas in July' event this weekend

News /

End Hunger Connecticut!’s Summer Meals Site Locator Map updated with more than 400 locations

News /

Glastonbury holds public forum to address rise in juvenile crime, prevention measures

News /
More Hartford

Trending Stories

Don't Miss

More Don't Miss